Medical/Pharmaceuticals
VISTA Eye Specialist Enhances Cataract Surgery with Advanced Technology and Strategic Partnerships
PETALING JAYA, Malaysia, March 14, 2025 /PRNewswire/ -- Klinik Pakar Mata VISTA Eye Specialist (VISTA), awell-established name in eye care in Malaysia, continues to improve itscataract surgery services through collaborations with recognized ophthalmic technology providers such as Johnson & Johnso...
2025-03-14 08:00
3071
MATELASER Introduces X1 Performance: The Ultimate Portable High-Energy Laser Therapy System for Pain Management
MIAMI, March 13, 2025 /PRNewswire/ -- MATELASER, INC., a pioneering force in laser therapy technology, is proud to announce the launch of the X1 Performance, the portable high-energy laser therapy system, designed to meet the highest U.S. medical quality standards for pain management, sports rec...
2025-03-13 22:00
2610
Insilico Medicine Secures $110 Million Series E Financing to Advance AI-Driven Drug Discovery Innovation
CAMBRIDGE, Mass., March 13, 2025 /PRNewswire/ -- Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced today that it has successfully secured a$110 million Series E financing led by a private equity fund of Value Partners ...
2025-03-13 21:00
3727
Amcor prices private offering of $2.2 billion of senior unsecured notes
ZURICH, March 13, 2025 /PRNewswire/ -- Amcor plc (NYSE:AMCR; ASX:AMC) ("Amcor") announced today that Amcor Flexibles North America, Inc. ("AFNA"), a wholly-owned subsidiary of Amcor, has priced a private offering (the "Offering") of guaranteed senior notes in an aggregate principal amount of$2.2 ...
2025-03-13 18:11
4248
IFPA Forum Americas 2025: "Towards More Equitable, Person-Centered Care for All People Living with Psoriatic Disease in the Americas"
On April 4, 2025, IFPA will host the IFPA Forum 2025 for the Americas in Bogotá, Colombia. This marks the third regional forum of its kind, following successful gatherings inEurope (2022) and Asia (2023). STOCKHOLM , March 13, 2025 /PRNewswire/ -- The IFPA Forum 2025 will unite stakeholders from...
2025-03-13 17:00
3092
KLN Selected by Teva as its Exclusive 4PL Service Provider in the Greater Bay Area
HONG KONG, March 13, 2025 /PRNewswire/ -- Kerry Logistics Network Limited ('KLN'; Stock Code 0636.HK), through its subsidiary, Kerry Pharma, and Teva Pharmaceutical Hong Kong Limited ('Teva') entered into an exclusive agreement for fourth-party logistics (4PL) distribution services inHong Kong, M...
2025-03-13 16:30
2984
WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025
SHANGHAI, March 13, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, has been honored with...
2025-03-13 13:54
2853
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors
SHANGHAI, March 13, 2025 /PRNewswire/ -- BioCity Biopharmaceutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that it has entered into a clinical trial collaboration agreement with MSD (Merck & Co., Inc., Rahway, NJ, USA), to evaluate the combination of BioCity's BC3195 ...
2025-03-13 13:17
9891
Caliber Launches 4 Analytics and AI-driven Solutions to Revolutionize Pharma Manufacturing and Quality
PITTSBURGH, March 13, 2025 /PRNewswire/ -- Caliber
2025-03-13 09:00
2458
GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‑Cell Lymphoma CD5 CAR-NK Therapy
YONGIN, South Korea, March 12, 2025 /PRNewswire/ -- GC Cell (KRX:144510), under the leadership of CEOSungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205), a novel CD5 CAR‑NK cell therapy. This "first patient dosing" marks a critical milestone in...
2025-03-13 07:30
2331
STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States
* STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. * Approved for the same indications as the reference product, STEQEYMA will be priced with a wholesale acquisition cost (WAC) list price at an 85% discount to the current WAC list price of STELARA to help...
2025-03-13 07:30
2438
Telix Adds Lead-212 Isotope Production Capability
MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated a breakthrough generator technology for the production of lead-212 (212Pb) and successfully completed...
2025-03-13 06:48
3744
111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025
SHANGHAI, March 12, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will par...
2025-03-12 19:00
2400
Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
CASTRES, France, CAMBRIDGE, Massachusetts and BASEL, Switzerland, March 12, 2025 /PRNewswire/ -- Pierre Fabre Laboratories and RedRidge Bio ("RedRidge") today announced an exclusive R&D collaboration and license agreement to identify and develop biparatopic antibody (BPA) drug candidates against ...
2025-03-12 17:00
2503
Caliway's CBL-514 Phase 2 Study (CBL-0202) Accepted for Publication in the Aesthetic Surgery Journal
Advancing Scientific Recognition in Non-Surgical Fat Reduction * Caliway's CBL-514 Phase 2 study (CBL-0202) has been accepted for publication inAesthetic Surgery Journal (ASJ), the top-ranked journal in aesthetic medicine and plastic surgery. * Clinical data (ITT population) showed that over ...
2025-03-12 14:29
2391
Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generation Obesity Therapies
- Élancé Therapeutics aims to improve current obesity treatment, specifically to increase overall body weight loss and fat mass loss, but preserve and even increase muscle and lean mass - Élancé Therapeutics will leverage HCAb-based bispecific antibody technology to advance these next-generation ...
2025-03-12 12:41
2337
AIM Vaccine's Serum-Free Iterative Rabies Vaccine Has Received Production License and Will Submit for Market Registration
Launch of Major Product Expected to Significantly Drive Performance Growth HONG KONG, March 12, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement onMarch 12, 2025, the company's serum-free iterative rabies vaccine has recently obtained...
2025-03-12 07:53
2564
Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U.S. FDA Clearance of IND Application for ASC47 in Combination with Semaglutide
* ASC47, an adipose-targeted muscle-preserving weight loss drug candidate for the treatment of obesity, demonstrated a half-life of up to 26 days and 40 days, respectively, in Phase Ib single subcutaneous injection studies in healthy subjects with elevatedlow-density lipoprotein cholesterol (LD...
2025-03-12 07:30
2927
Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH
RAICHUR, India , March 12, 2025 /PRNewswire/ -- Shilpa Medicare Limited
2025-03-12 05:30
3320
Flat Medical Announces Key U.S. Leadership Appointments
PITTSBURGH, PA., March 11, 2025 /PRNewswire/ -- Flat Medical announces strategic additions and promotions to its U.S. executive leadership team, positioning the company for continued growth in the North American medical technology sector. Mark Rabe has joined Flat Medical as Director of Sales an...
2025-03-11 22:30
2246
Week's Top Stories
Most Reposted
Sustainable Tourism Impact Fund Expands Investments Across Southeast Asia
[Picked up by 309 media titles]
2026-04-03 11:30
Visa cements global K-pop connection as Worldwide Tour Sponsor for "BTS WORLD TOUR 'ARIRANG'"
[Picked up by 307 media titles]
2026-04-06 10:00
UTP Advances Across Key Disciplines in QS World University Rankings By Subject 2026 - Petroleum Engineering Among World's Top 10
[Picked up by 298 media titles]
2026-04-06 16:46
Marriott Bonvoy Returns as an Official Partner of the Cathay/HSBC Hong Kong Sevens 2026
[Picked up by 290 media titles]
2026-04-02 18:13
OneQode, Hitachi Vantara & Cylix Form Strategic Alliance to Launch Sovereign AI Factory Initiative
[Picked up by 282 media titles]
2026-04-08 08:00
Most Read
LightInTheBox Files 2025 Annual Report on Form 20-F
2026-04-02 20:00
6495
ECARX Announces Audited 2025 Full-Year Financial Results
2026-04-02 21:06
5774
Korea's Supreme Court Upholds Korea Zinc's Voting Restriction, Rebuffing Young Poong's Legal Challenge
2026-04-03 21:00
5735
